Voglimik GM 2mg/500mg/0.2mg Tablet
Marketer
Mikayla Life Sciences Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglimik GM 2mg/500mg/0.2mg Tablet
Diabetol Trio 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetol Trio should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to hyperglycemia and potentially serious complications including nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication forms part of a comprehensive diabetes management plan encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly contribute to diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect; learn to recognize its symptoms (sweating, dizziness, headache, tremor) and how to treat it. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended by your doctor.
Uses of Voglimik GM 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Voglimik GM 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglimik GM 2mg/500mg/0.2mg tablets should be administered on an empty stomach.
Common Side effects of Voglimik GM 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglimik GM 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Voglimik GM 2mg/500mg/0.2mg tablets should be administered on an empty stomach.
How Voglimik GM 2mg/500mg/0.2mg Tablet works:
Each Voglimik GM 2mg/500mg/0.2mg tablet contains a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimik GM 2mg/500mg/0.2mg Tablet with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using Voglimik GM 2mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Voglimik GM 2mg/500mg/0.2mg Tablets while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Voglimik GM 2mg/500mg/0.2mg tablets poses a likely risk for individuals with kidney impairment and should be forgone. Medical advice is essential. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglimik GM 2mg/500mg/0.2mg tablets cautiously. Dosage modification may be necessary. Consult your physician. A reduced starting dose is usually advised for individuals with mild to moderate liver disease; this medication is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Voglimik GM 2mg/500mg/0.2mg Tablet :
Should you forget a dose of Voglimik GM 2mg/500mg/0.2mg Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed dose.
Facts to Know About Voglimik GM 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently